The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biweekly cabazitaxel as post-docetaxel treatment for metastatic castration resistant prostate cancer (mCRPC): Findings from an early safety analysis of the Prosty II trial.
 
Pirkko-Liisa Irmeli Kellokumpu-Lehtinen
Honoraria - Amgen; Lilly; Roche; Sanofi
Consulting or Advisory Role - Pfizer; Roche
Research Funding - Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Merck; Roche; Sanofi
 
Timo Marttila
Honoraria - Astellas Pharma; Bayer; Janssen-Cilag; Sanofi
Consulting or Advisory Role - Astellas Pharma
Expert Testimony - Janssen-Cilag
Travel, Accommodations, Expenses - Allergan; Ferring; Janssen-Cilag
 
Petteri Hervonen
Honoraria - Bayer; Janssen-Cilag
Consulting or Advisory Role - Janssen-Cilag
 
Vesa V Kataja
Honoraria - Bayer; GlaxoSmithKline; Merck
Consulting or Advisory Role - Astellas Pharma; Merck
Research Funding - Bayer; MSD; Sanofi
 
Tapio Utriainen
No Relationships to Disclose
 
Marjaana Luukkaa
Consulting or Advisory Role - Amgen; Bayer; Sanofi
 
Mikko Taalikka
No Relationships to Disclose
 
Anna-Liisa Kautio
No Relationships to Disclose